US Patent 7855211 Protein kinase inhibitors
Patent 7855211 was granted and assigned to Eli Lilly and Company on December, 2010 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7855211 Protein kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
